Crossmark

Efficacy and safety of once-daily single-inhaler triple therapy for mild-to-moderate chronic obstructive pulmonary disease: a study protocol for a randomised and interventional study

Crossref DOI link: https://doi.org/10.1136/bmjresp-2022-001607

Published Online: 2023-05-17

Published Print: 2023-05

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Takahashi, Koichiro https://orcid.org/0000-0003-0461-5072
Kawayama, Tomotaka

Takamori, Ayako

Tashiro, Hiroki

Kinoshita, Takashi

Takagi, Koichi

Yamasaki, Kei

Machida, Kentaro

Kawaguchi, Atsushi

Yatera, Kazuhiro https://orcid.org/0000-0002-2955-4432
Inoue, Hiromasa https://orcid.org/0000-0001-8080-3812
Funding

Funding for this research was provided by:

GlaxoSmithKline
License Information

License valid from 2023-05-17

Document is current

Any future updates will be listed below